Korro Bio, Inc.
KRRO
$20.26
$0.190.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.19% | -10.32% | -0.95% | 3.79% | -11.60% |
| Total Depreciation and Amortization | 0.16% | -2.23% | 44.86% | 19.97% | -0.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.24% | 23.94% | 15.50% | -42.13% | -7.83% |
| Change in Net Operating Assets | 181.36% | -134.62% | 280.69% | -36.26% | 189.82% |
| Cash from Operations | 21.36% | -226.24% | 53.43% | -10.29% | 33.34% |
| Capital Expenditure | -17.65% | 91.80% | 70.23% | 18.17% | -6.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -133.92% | 2,605.71% | 82.95% | 92.02% | -- |
| Cash from Investing | -134.47% | 1,285.57% | 78.02% | 87.72% | -1,724.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.09% | -81.55% | 28.02% | -98.92% | 48,501.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.09% | -81.55% | 28.02% | -98.92% | 48,501.44% |
| Foreign Exchange rate Adjustments | -- | -- | -400.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 200.00% | -- | -- |
| Net Change in Cash | -459.16% | 191.10% | 66.61% | 43.47% | -80.65% |